Shopping Cart
Remove All
Your shopping cart is currently empty
BI-836858 is a fully humanized IgG1 anti-CD33 monoclonal antibody. It is modified at the Fc fragment to enhance binding with FcγRIIIa (CD16). BI-836858 exhibits antibody-dependent cellular cytotoxicity (ADCC) activity and is utilized in research related to acute myeloid leukemia (AML).
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | BI-836858 is a fully humanized IgG1 anti-CD33 monoclonal antibody. It is modified at the Fc fragment to enhance binding with FcγRIIIa (CD16). BI-836858 exhibits antibody-dependent cellular cytotoxicity (ADCC) activity and is utilized in research related to acute myeloid leukemia (AML). |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.